|
Home > Articles
Radiofrequency ablation of pulmonary tumours: current status
Abstract
Radiofrequency ablation (RFA) for thoracic tumours has emerged as a minimally invasive therapy option for primary
and secondary lung tumours and has gained increasing acceptance for pain palliation. The procedure is well tolerated
and the complication rates are low. RFA provides the opportunity for localized tissue destruction of limited tumour
volumes with medium and long term follow-up data suggesting that survival figures do parallel those of non-surgical
treatment modalities. The purpose of this article is to review the status of RFA in lung tumours, to emphasize its place
in symptomatic palliation and to discuss its potential role in conjunction with radiation or systemic therapy.
Author
Karin Steinke
Contact Details
Corresponding address:
Karin Steinke, RBWH, Department of Medical Imaging, Butterfield Street,
Herston, Queensland 4029, Australia
Reference
ICIS Cancer Imaging Volume 8 Issue 1
DOI: 10.1102/1470-7330.2008.0008
Date Posted
3 March 2008
Open Access is provided for this article.
Print PDF
Size
1.33 MB
Minimum Estimated Download Times
ADSL 2Mb/s (Broadband): |
5 seconds |
ADSL 512Kb/s (Broadband): |
21 seconds |
64 Kb/s (ISDN): |
2 minutes 49 seconds |
33.3 Kb/s (Typical Modem): |
5 minutes 26 seconds |
|
